These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2080247)

  • 21. The neuroendocrine phenotype, cellular plasticity, and the search for genetic switches: redefining the diffuse neuroendocrine system.
    Day R; Salzet M
    Neuro Endocrinol Lett; 2002; 23(5-6):447-51. PubMed ID: 12500170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin.
    Xing N; Qian J; Bostwick D; Bergstralh E; Young CY
    Prostate; 2001 Jun; 48(1):7-15. PubMed ID: 11391682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine differentiation in prostatic carcinoma: an update.
    di Sant'Agnese PA
    Prostate Suppl; 1998; 8():74-9. PubMed ID: 9690666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors.
    Wafa LA; Palmer J; Fazli L; Hurtado-Coll A; Bell RH; Nelson CC; Gleave ME; Cox ME; Rennie PS
    Hum Pathol; 2007 Jan; 38(1):161-70. PubMed ID: 16997353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells.
    Untergasser G; Plas E; Pfister G; Heinrich E; Berger P
    Prostate; 2005 Sep; 64(4):419-29. PubMed ID: 15800938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation into the role of Bcl-2 in neuroendocrine differentiation.
    Cadden IS; Johnston BT; Connolly R; Gates D; Tsujimoto Y; Eguchi Y; McGinty A
    Biochem Biophys Res Commun; 2005 Jan; 326(2):442-8. PubMed ID: 15582597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuroendocrine system and neuroendocrine tumors].
    Schulz HJ
    Zentralbl Pathol; 1993 Jun; 139(2):93. PubMed ID: 8369270
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence and prognostic significance of endocrine cells in colorectal adenocarcinomas.
    Lapertosa G; Baracchini P; Delucchi F
    Pathologica; 1994 Apr; 86(2):170-3. PubMed ID: 7936761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies.
    Casella R; Bubendorf L; Sauter G; Moch H; Mihatsch MJ; Gasser TC
    J Urol; 1998 Aug; 160(2):406-10. PubMed ID: 9679888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate.
    Xue Y; Verhofstad A; Lange W; Smedts F; Debruyne F; de la Rosette J; Schalken J
    Am J Pathol; 1997 Dec; 151(6):1759-65. PubMed ID: 9403726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine cell proliferation associated with primary pulmonary MALT lymphoma.
    Rosso R; Boveri E; Paulli M; Fiocca R; Magrini U
    Histopathology; 1996 Jul; 29(1):78-80. PubMed ID: 8818700
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neuroendocrine system and its tumors].
    Schulz HJ; Ladhoff A
    Zentralbl Pathol; 1993 Jun; 139(2):101-6. PubMed ID: 8103675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Searching for an intrinsic neuroendocrine cell in the kidney.
    Kawabata K
    Pathol Res Pract; 1999; 195(12):865-6. PubMed ID: 10631725
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications.
    Theodoropoulos VE; Tsigka A; Mihalopoulou A; Tsoukala V; Lazaris AC; Patsouris E; Ghikonti I
    Urology; 2005 Oct; 66(4):897-902. PubMed ID: 16230178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2.
    Diaz M; Abdul M; Hoosein N
    Prostate Suppl; 1998; 8():32-6. PubMed ID: 9690661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilomatricoma-like endometrioid adenosquamous carcinoma of the ovary with neuroendocrine differentiation.
    Fang J; Keh P; Katz L; Rao MS
    Gynecol Oncol; 1996 May; 61(2):291-3. PubMed ID: 8626150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas.
    Gestblom C; Hoehner JC; Hedborg F; Sandstedt B; Påhlman S
    Am J Pathol; 1997 Jan; 150(1):107-17. PubMed ID: 9006328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems.
    Hoffman GE; Smith MS; Verbalis JG
    Front Neuroendocrinol; 1993 Jul; 14(3):173-213. PubMed ID: 8349003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary on the use of immortalized neuroendocrine cell lines for physiological research.
    Selmanoff M
    Endocrine; 1997 Feb; 6(1):1-3. PubMed ID: 9225108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.